Machine Learning

With Vitalik Buterin, BlackRock, and government leaders, Hong Kong's Web3 Fest signals a major push to merge TradFi with the future of digital assets.

A landmark grant funds research into scaffold-free tissue, a revolutionary approach that could one day eliminate the need for many knee replacements.

The Jackson Laboratory appoints Steven Holstein to bridge science and capital, supercharging its new integrated platform for developing breakthrough therapies.

French firms Clean Cells and Naobios eye South Korea's booming biopharma sector, offering a rare integrated solution for viral vaccine and therapy development.

A global partnership aims to bring Atla-cel, a next-gen CAR-T therapy with low neurotoxicity, to children with leukaemia, potentially revolutionizing treatment.

AriseAlpha's new app promises easy crypto returns, replacing costly mining rigs. But can automated bots truly outsmart the market's notorious volatility?

With the U.S. government's top security clearance, Cav's AI platform is set to automate compliance and transform security for the nation's most critical agencies.

A new once-daily pill for hypoparathyroidism begins human testing, promising to replace burdensome injections and transform patient care. Is this the future?

The Texas Rangers' new deal with Priority Commerce goes beyond sponsorship, signaling a major shift in how pro sports teams manage complex financial operations.

A 2km gold anomaly found under deep cover could signal a major new discovery in Namibia, validating innovative exploration in a burgeoning gold frontier.

A Canadian drone maker gains top military approval in Ukraine, leveraging its unique 'ITAR-flexible' status to meet surging global defense demand.

With denial rates soaring, RapidClaims launches RapidRecovery, an AI solution aimed at creating a fully automated, end-to-end healthcare revenue cycle.

The FDA has cleared the first 'theragnostic' sleep apnea device, integrating treatment and monitoring to usher in an era of data-driven, personalized care.

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

Fresh off a massively oversubscribed IPO, Chinese robotics firm Huayan debuts at Hannover Messe, challenging industry giants with advanced AI and automation.

Entrust adds two senior executives to fortify its operations and customer success, signaling a strategic response to the rising threats and opportunities of AI.

Backed by Maria Sharapova, new startup Amulet launches a science-first supplement aiming to optimize women's performance throughout their entire cycle.

Biotech firm Epitopea adds top expert Dr. Lisa Butterfield, validating its novel RNA vaccine approach targeting hidden cancer antigens for hard-to-treat tumors.

A major tech firm's new 100,000 sq ft facility in Swanton signals a strategic corporate play and a significant economic boost for Northwest Ohio.

As PE firms struggle to turn AI hype into profit, Jefferies' strategic investment in Decision Science Advisors signals a new focus on practical results.